NAFDAC refutes PAXHERBAL claim on drug for treatment of COVID-19

The National Agency for Food and Drug Administration and Control (NAFDAC), has disassociated itself from PAXHERBAL advertorial claim that it has developed a drug for the treatment of COVID-19.

PAXHERBAL is a clinic and a research laboratory, also known as Pax Herbal Clinic and Research Laboratory, a Nigerian alternative medicine product manufacturing company.

It had issued an advertorial to the public titled: “An official statement by Pax herbal on the treatment of COVID-19.”

The advertorial claimed that Pax Herbal Clinic has developed a new drug called: PAX CVD PLUS for the treatment of COVID-19 and that the laboratory is working with NAFDAC to speed up approval for the use of the drugs.

The advertorial was also alleged to have claimed that NAFDAC Director-General, Prof Mojisola Adeyeye, has appointed experts to work with Paxherbal on what the laboratory described as a special project.

Meanwhile, in a statement obtained by News Agency of Nigeria (NAN), in Abuja on Saturday, NAFDAC DG refuted the collaboration, adding that the laboratory was yet to be registered with the agency or listed for the treatment of COVID-19.

“The attention of the Agency has been drawn to an advertorial from Paxherbal clinic and research laboratories, NAFDAC wishes to inform the public that PAX CVD PLUS has not been registered nor listed for treatment of COVID-19.

“To set the records straight, at no time did the DG or anyone in the agency appoint any expert or staff to work with Paxherbal on any project.

“The company wrote a letter to NAFDAC informing the agency about their development of an antiviral plant-based drug with potential to treat COVID-19 and an invitation to join their research team.

“The Agency politely declined since as a regulator of clinical trials, participation would be a conflict of interest.

“However, we encouraged them to carry out clinical trials which should be under strict supervision of the agency to establish efficacy of their product.

“However, the clinical trial has not taken place,” NAFDAC said.

According to the agency, it was unfortunate that PAXHERBAL has made claims that were not backed up by facts and this response was intended to correct the erroneous impression created by the advertorial.

(NAN)

YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE

Buy and read digital replicas of your TRIBUNE titles by subscribing through E-VENDING

COVID-19: Dokpesi, Daughter-In-Law, Six Other Family Members Test Positive
The founder of DAAR Communications Plc, High Chief Raymond Dokpesi and his daughter-in-law along with six members of his family have tested positive for coronavirus. This is coming three days after his son and Chairman of the board of the company, Raymond Dokpesi Jnr, also tested positive for the virus… Read full story

Kano And The Mad Woman Of Omu-Ijelu
Not long ago, the funny character, who presides over the affairs of Kano State as the governor, Umar Ganduje, raised the alarm that the Federal Government had literarily abandoned the state in its quest to combat the rampaging Coronavirus epidemic… Read full story

Lagos Discharges Polish, Filipino, 24 Nigerians After Testing Negative For Coronavirus
Lagos State governor, Babajide Sanwo-Olu, on Friday announced that 26 more patients have been discharged from isolation centres in the state having tested negative twice consecutively to coronavirus. He said those discharged included 14 males and 12 females, including two foreign nationals – a Polish and a Filipino… Read full story

WHO To Identify Animal Source Of COVID-19 ― Director-General
Dr Tedros Ghebreyesus, the Director-General, World Health Organisation (WHO), said the agency will work with relevant organisations to identify the animal source of novel Coronavirus (COVID-19) based on Emergency Committee recommendations… Read full story

COVID-19: Workers Won’t Be Retrenched Without Following Due Process, Says Buhari
President Muhammadu Buhari has told workers that despite the expected downturn in the nation’s economy owing to the coronavirus pandemic, the Federal Government will ensure that workers won’t be retrenched without due process. Seeking to allay the fears of workers for their jobs, which has heightened recently… Read full story